首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Brachytherapy

Brachytherapy杂志,由Elsevier Inc.出版,于2002年创刊,Quarterly,出版语言English,ISSN:1538-4721,E-ISSN:1873-1449。

投稿咨询
Brachytherapy
Brachytherapy
Brachytherapy
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
3区
影响因子
1.7
CiteScore
2.8
期刊收录
SCI、SCIE

Brachytherapy(中文译名:《近距离放射治疗》),ISSN:1538-4721,EISSN:1873-1449,是Elsevier Inc.出版的国际性学术期刊,创刊于2002年,以Quarterly形式稳定发行,2026年总发文量约101篇。该刊采用非OA开放访问,学科归属为医学 - 核医学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达1.7,2025年期刊CiteScore为2.8,2025年期刊自引率约23.5%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Brachytherapy长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACanada、France、CHINA MAINLAND、Netherlands、GERMANY (FED REP GER)、Japan等为核心发文国家与地区;UNIVERSITY OF TEXAS SYSTEMUNIVERSITY OF TORONTO、UNIVERSITY OF CALIFORNIA SYSTEM、SUNNYBROOK HEALTH SCIENCE CENTER、UNICANCER、MEMORIAL SLOAN KETTERING CANCER CENTER、VIRGINIA COMMONWEALTH UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区 4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区 4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q4 273 / 333

18.2

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 137 / 217

37.1

学科:ONCOLOGY SCIE Q3 246 / 333

26.28

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 145 / 217

33.41

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q4 253 / 328

23

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 125 / 213

41.5

学科:ONCOLOGY SCIE Q3 234 / 328

28.81

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 141 / 213

34.04


中国学者近期发文

1
Ultrasound and CT-guided 125I implantation combined with TACE therapy in the treatment of recurrent HCC after RF

Author:Li, Ningjie; Yang, Ping; Fang, Jun; Li, Hongbo; Wan, Yulei; Wu, Xizi; Wang, Li

Journal: BRACHYTHERAPY. 2026; Vol. 25, Issue 2, pp. 325-332. DOI: 10.1016/j.brachy.2025.11.001

2
Improved outcomes in primary hepatocellular carcinoma adjacent to large vessels: A combined approach of MRI-guided radiofrequency ablation and 125 I implantatio

Author:Miao, Xianhua; Guo, Rui; Lin, Qingfeng; Lin, Zhengyu

Journal: BRACHYTHERAPY. 2026; Vol. 25, Issue 2, pp. 333-341. DOI: 10.1016/j.brachy.2025.12.005

3
AI-assisted 3D-printed transvaginal template guidance for interstitial brachytherapy in patients with cervical cancer with parametrial invasio

Author:Li, Huiling; Li, Xiuhua; Zhang, Jianqiu; Dai, Yitao; Lin, Huijuan; Xie, Xingyun; Yang, Meichun

Journal: BRACHYTHERAPY. 2026; Vol. 25, Issue 1, pp. 95-106. DOI: 10.1016/j.brachy.2025.10.011

4
Intraluminal brachytherapy using 125I seed strand combined with PTBD and Hepatic arterial infusion chemotherapy for unresectable Bismuth-Corlette III and IV stage hilar cholangiocarcinom

Author:Zhang, Zi-Han; Li, Min; Sun, Hui-Yi; Yang, Min-Jie; Yan, Zhi-Ping; Li, Fu-You; Liu, Ling-Xiao

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 3, pp. 431-438. DOI: 10.1016/j.brachy.2024.12.004

5
Quality control study of cervical cancer interstitial brachytherapy treatment plans using statistical process contro

Author:Chen, Xiao; Shi, Xiangxiang; Zhang, Huaiwen; Pang, Haowen

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 3, pp. 371-378. DOI: 10.1016/j.brachy.2024.12.007

6
Efficacy and safety of chemotherapy combined with iodine-125 seed brachytherapy for intermediate and advanced oncogenic driver gene-negative non-small cell lung cance

Author:Xia, Meng-hua; Liu, Kai-cai; Zhao, Wei; Cheng, Yi-zhuang; Shi, Liang-ping; Bi, Li-qin; Guo, Xue-ran; Zhang, Meng-xia; Lv, Wei-Fu

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 1, pp. 92-102. DOI: 10.1016/j.brachy.2024.09.005

7
Deficits of proactive control in individuals with test anxiety: Evidence from ERP

Author:Wang, Lei; Zhou, Renlai

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 1, pp. -. DOI: 10.1016/j.biopsycho.2025.108985

8
Establishment of an absolute measurement of the reference air kerma rate for HDR 192 Ir brachytherapy source

Author:Han, Jinpeng; Zhi, Shijie; Wang, Peiwei; Wang, Ji; Yang, Zhijun; Wang, Kun; An, Xingtao

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 1, pp. 110-121. DOI: 10.1016/j.brachy.2024.09.006


在线咨询

Brachytherapy

国际简称:BRACHYTHERAPY参考译名:近距离放射治疗

年发文量:101 CiteScore:2.8 是否预警:否 Gold OA文章占比:10.49% 研究类文章占比:94.06%

杂志社联系方式:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Brachytherapy